Acute Promyelocytic Leukemia


Pass It On: July is National Leukemia and Lymphoma Awareness Month (September 1, 2016)

Leukemia and lymphoma are both hematologic malignancies, meaning that they involve the blood or bone marrow. The American Cancer Society (ACS) estimates that there will be 60,140 new cases of leukemia... Continue Reading

Ask the Expert: Blood Cancer Treatment Progress & What’s Next (October 7, 2015)

CancerConnect Presents: Ask the Expert: Blood Cancer Treatment Progress & What’s Next In this informative web chat, Jacqueline Barrientos, MD discusses blood cancer prevalence, evolution of blood... Continue Reading

September Is National Blood Cancer Awareness Month (September 5, 2014)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of blood cancer educational programs for national blood cancer awareness month. As the month of September brings blood... Continue Reading

Caring for Yourself During Chemotherapy for Leukemia: How to Manage Hair Loss, Dry Skin, and Brittle Nails (June 3, 2012)

Chemotherapy can be effective treatment for cancer but may also cause physical side effects that may be uncomfortable and affect your appearance. These side effects, however, are manageable. Hair Loss Hair... Continue Reading

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

A study of “chemo brain”—the foggy thinking and forgetfulness that patients may experience after chemotherapy—suggests that the condition improves substantially over time for a majority of patients.... Continue Reading

September Is National Leukemia and Lymphoma Awareness Month (August 28, 2009)

As the month of September brings leukemia and lymphoma into focus, it’s time to increase public understanding of these diseases, including their prevalence, approaches to screening and prevention, treatment... Continue Reading

Arsenic Trioxide Effective as Single Agent in Newly Diagnosed APL (March 31, 2006)

Arsenic Trioxide Effective as Single Agent in Newly Diagnosed APL According to an article recently published in the journal Blood, the agent arsenic trioxide, when used as a single agent, provides impressive... Continue Reading

Elderly with Acute Promyelocytic Leukemia Achieve Long-Term Survival with Treatment (August 19, 2004)

Elderly with Acute Promyelocytic Leukemia Achieve Long-Term Survival with Treatment According to results published in a recent advanced online article in the journal Blood, long-term cancer-free survival... Continue Reading

ATRA Plus Trisenox®: A Promising Treatment for Acute Promyelocytic Leukemia (December 17, 2003)

ATRA Plus Trisenox®: A Promising Treatment for Acute Promyelocytic Leukemia According to results presented at the 2003 annual meeting of the American Society of Hematology, the combination... Continue Reading

Intensified Induction Therapy May Reduce Relapses in APL (March 5, 2002)

Intensified Induction Therapy May Reduce Relapses in APL According to results recently presented at the 43 rd annual meeting of the American Society of Hematology, evidence suggests that patients... Continue Reading

Patients Die Unexpectedly Following Treatment with Arsenic Trioxide (February 21, 2002)

Patients Die Unexpectedly Following Treatment with Arsenic Trioxide Three sudden deaths occurred in a small clinical trial involving patients treated with arsenic trioxide for recurrent acute promyelocytic... Continue Reading

FDA Approves Arsenic for Treatment of Promyelocytic Leukemia (February 21, 2002)

FDA Approves Arsenic for Treatment of Promyelocytic Leukemia The Food and Drug Administration has recently approved a chemotherapy agent, arsenic, for patients with acute promyelocytic leukemia who... Continue Reading

Arsenic: An Effective New Treatment for Acute Promyelocytic Leukemia (February 21, 2002)

Arsenic: An Effective New Treatment for Acute Promyelocytic Leukemia Acute promyelocytic leukemia is a cancer of the blood. Initial treatment typically consists of all-trans retinoic acid (ATRA) and... Continue Reading

New Techniques Allowing Earlier Detection of Leukemia Recurrence and Prompt Treatment May Improve Outcomes for Patients with Acute Promyelocytic Leukemia (February 21, 2002)

New Techniques Allowing Earlier Detection of Leukemia Recurrence and Prompt Treatment May Improve Outcomes for Patients with Acute Promyelocytic Leukemia Patients with acute promyelocytic leukemia... Continue Reading

Remissions Induced by Liposomal-Encapsulated All-Trans Retinoic Acid in Newly Diagnosed Patients with Acute Promyelocytic Leukemia (February 21, 2002)

Remissions Induced by Liposomal-Encapsulated All-Trans Retinoic Acid in Newly Diagnosed Patients with Acute Promyelocytic Leukemia All-trans retinoic acid administered orally (oral ATRA) is a component... Continue Reading

All transretinoic acid (ATRA) combined with chemotherapy results in superior outcomes for patients with acute promyelocytic leukemia. (February 21, 2002)

All transretinoic acid (ATRA) combined with chemotherapy results in superior outcomes for patients with acute promyelocytic leukemia. It has been known for several years that ATRA is an active drug... Continue Reading

Arsenic may be a very active anti-cancer agent for the treatment of patients with acute leukemia. (February 21, 2002)

Arsenic may be a very active anti-cancer agent for the treatment of patients with acute leukemia. Current standard treatment of acute promyelocytic leukemia utilizes all-trans-retinoic acid; however,... Continue Reading

Treatment of Leukemia: Allogeneic Transplant Using Peripheral Blood Stem Cells, Rather than Marrow Stem Cells, Is Associated with Faster Blood Count Recovery (February 18, 2002)

Treatment of Leukemia: Allogeneic Transplant Using Peripheral Blood Stem Cells, Rather than Marrow Stem Cells, Is Associated with Faster Blood Count Recovery High-dose chemotherapy with stem cell... Continue Reading

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS